Briumvi






A random reporter with supposedly good track record posted something similar on X several weeks ago, but who knows if accurate. Especially because that same post said Roche was in the mix, which would not fly with regulators. Other boards are saying Sanofi and BMY are in mix, but neither was on reporter's list.
 


A random reporter with supposedly good track record posted something similar on X several weeks ago, but who knows if accurate. Especially because that same post said Roche was in the mix, which would not fly with regulators. Other boards are saying Sanofi and BMY are in mix, but neither was on reporter's list.
Either way, with no sales incentives here anymore, no one works and we are lucky Ocrevus sells itself. The best days are behind us!
 


Either way, with no sales incentives here anymore, no one works and we are lucky Ocrevus sells itself. The best days are behind us!
3/4 of the people who left GNE to go to TG would come back in a heartbeat if they could. Complain all you want, but grass isn’t greener and now they’re gonna end up working for big pharma micro manager or laid off.
 


I totally agree. Most now know they made a mistake. I suppose there is a chance that a buyout won't happen and TG continues alone, but that seems unlikely. And even if TG doesn't get bought in next few weeks, I'd venture that at least 75% of the 3/4ths don't like the culture over there. I bet our phones will be ringing soon, by JPM conference perhaps?
 


I totally agree. Most now know they made a mistake. I suppose there is a chance that a buyout won't happen and TG continues alone, but that seems unlikely. And even if TG doesn't get bought in next few weeks, I'd venture that at least 75% of the 3/4ths don't like the culture over there. I bet our phones will be ringing soon, by JPM conference perhaps?
Trust me when I say that none of us at TG want to go back to Genentech. What's left of the former Ocrevus launch team are the losers who can't find work elsewhere or are too lazy to look for jobs. Too funny. Trust me when I say that Genentech means nothing on a resume anymore. All other companies understand what's happening in the land of Oz - I mean ecosystem
 


Trust me when I say that none of us at TG want to go back to Genentech. What's left of the former Ocrevus launch team are the losers who can't find work elsewhere or are too lazy to look for jobs. Too funny. Trust me when I say that Genentech means nothing on a resume anymore. All other companies understand what's happening in the land of Oz - I mean ecosystem
OK "Associate Director of Whatever"

Is this why you still spend time on your ex company's CP page? Lol...taking time off of trolling our LinkedIn pages?
 


Either way, with no sales incentives here anymore, no one works and we are lucky Ocrevus sells itself. The best days are behind us!
No one can sell here anyway! I mean is that word even allowed here? Nevermind the incentive, let alone having the skill to sell anything, which we don’t have!

Average field person makes 1-2 “sales” calls per day. I would be curious of the 10 calls made in a week what percent were with a person that could actually put “pen to paper” (physician or APP) or are we going to pretend that an email to a nurse or pharmacist is a “sales call?”

Just stop!
 


OK "Associate Director of Whatever"

Is this why you still spend time on your ex company's CP page? Lol...taking time off of trolling our LinkedIn pages?
They don't need to, bots can do it.

Btw anyone need a sales call bot? There are some out now and from what i understand they can tether to your unix and be set on auto. Time for cabo
 



Write your reply...